HUT77128A - 1,2,4-Triazol-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények - Google Patents

1,2,4-Triazol-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUT77128A
HUT77128A HU9700109A HU9700109A HUT77128A HU T77128 A HUT77128 A HU T77128A HU 9700109 A HU9700109 A HU 9700109A HU 9700109 A HU9700109 A HU 9700109A HU T77128 A HUT77128 A HU T77128A
Authority
HU
Hungary
Prior art keywords
pct
preparation
pharmaceutical compositions
compositions containing
triazole derivatives
Prior art date
Application number
HU9700109A
Other languages
English (en)
Other versions
HU9700109D0 (en
HU225961B1 (en
Inventor
Siegfried Bialojan
Karla Drescher
Beate Hellendahl
Annegret Lansky
Rainer Munschauer
Hans-Jürgen Teschendorf
Liliane Unger
Karsten Wicke
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6523323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT77128(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of HU9700109D0 publication Critical patent/HU9700109D0/hu
Publication of HUT77128A publication Critical patent/HUT77128A/hu
Publication of HU225961B1 publication Critical patent/HU225961B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9700109A 1994-07-15 1995-07-14 1,2,4-triazole derivatives, process for their preparation and pharmaceutical compositions containing them HU225961B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4425144A DE4425144A1 (de) 1994-07-15 1994-07-15 Triazolverbindungen und deren Verwendung

Publications (3)

Publication Number Publication Date
HU9700109D0 HU9700109D0 (en) 1997-02-28
HUT77128A true HUT77128A (hu) 1998-03-02
HU225961B1 HU225961B1 (en) 2008-01-28

Family

ID=6523323

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700109A HU225961B1 (en) 1994-07-15 1995-07-14 1,2,4-triazole derivatives, process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US6124294A (hu)
EP (1) EP0772604B1 (hu)
KR (1) KR100379196B1 (hu)
CN (1) CN1068314C (hu)
AT (1) ATE179703T1 (hu)
AU (1) AU703889B2 (hu)
BG (1) BG63500B1 (hu)
BR (1) BR9508294A (hu)
CA (1) CA2195243C (hu)
CZ (1) CZ292625B6 (hu)
DE (2) DE4425144A1 (hu)
DK (1) DK0772604T3 (hu)
ES (1) ES2131842T3 (hu)
FI (1) FI970147A (hu)
GR (1) GR3030371T3 (hu)
HU (1) HU225961B1 (hu)
IL (1) IL114598A (hu)
NO (1) NO315320B1 (hu)
NZ (1) NZ290387A (hu)
RU (1) RU2167869C2 (hu)
SI (1) SI9520083A (hu)
WO (1) WO1996002520A1 (hu)
ZA (1) ZA955867B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600934A1 (de) 1996-01-12 1997-07-17 Basf Ag Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
DE19728996A1 (de) * 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
WO2000021951A1 (en) 1998-10-08 2000-04-20 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
WO2001024796A1 (en) 1999-10-01 2001-04-12 Smithkline Beecham Corporation 1,2,4-triazole derivatives, composition, process of making and methods of use
WO2001072306A1 (de) * 2000-03-27 2001-10-04 Basf Aktiengesellschaft Verwendung von dopamin-d3-rezeptor-liganden zur behandlung von erkrankungen des zentralen nervensystems
DE10109867A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
AU2003267201B2 (en) 2002-09-14 2009-04-23 The Gov't Of The U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Structurally rigid dopamine D3 receptor selective ligands and process for making them
CZ300500B6 (cs) * 2002-11-11 2009-06-03 Zpusob uzavírání špic v pletacím stroji
DE10304870A1 (de) 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
TW200510395A (en) * 2003-06-05 2005-03-16 Abbott Gmbh & Co Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
US6919342B2 (en) 2003-06-05 2005-07-19 Abbott Gmbh & Co. Kg Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
DE10358004A1 (de) 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
MXPA06006858A (es) 2003-12-18 2006-09-04 Abbott Gmbh & Co Kg Tetrahidrobenzacepinas y su uso en la modulacion del receptor d3 de la dopamina.
US20050137186A1 (en) 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
ATE452134T1 (de) * 2004-08-09 2010-01-15 Abbott Gmbh & Co Kg Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
MX2007006598A (es) * 2004-12-02 2007-09-21 Abbott Gmbh & Co Kg Compuestos de triazol adecuados para tratar trastornos que responden a la modulacion del receptor de dopamina d3.
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
GB2454290B (en) * 2007-08-07 2009-09-30 Prosarix Ltd Novel serotonergic modulators
PA8802101A1 (es) 2007-11-02 2009-08-26 Abbott Gmbh & Co Kg Compuestos de 1,2,4-3,5-diona adecuados para el tratamiento de trastornos que responden a la modulación del receptor de dopamina d3
SI2298747T1 (sl) * 2008-07-03 2017-08-31 Astellas Pharma Inc. Derivat triazola ali njegova sol

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053085A (hu) * 1964-03-26
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4408049A (en) * 1980-09-17 1983-10-04 The Upjohn Company Substituted piperazinyl-1,2,4-triazoles
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4577020A (en) * 1983-01-25 1986-03-18 The Upjohn Company Aminoalkyl and aminoalkenyl triazoles as anti-psychotic agents
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
FR2580648B1 (fr) * 1985-04-17 1987-05-15 Adir Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2601952B1 (fr) * 1986-07-23 1988-11-25 Carpibem Nouveaux derives amino alkyl thio de triazolopyridine ou triazoloquinoline, leurs procedes de preparation, medicaments les contenant, utiles notamment comme antalgiques
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones

Also Published As

Publication number Publication date
BG63500B1 (bg) 2002-03-29
CZ292625B6 (cs) 2003-11-12
KR100379196B1 (ko) 2003-06-11
ZA955867B (en) 1997-01-14
CN1152919A (zh) 1997-06-25
IL114598A0 (en) 1995-11-27
EP0772604B1 (de) 1999-05-06
HU9700109D0 (en) 1997-02-28
NO315320B1 (no) 2003-08-18
JP4114950B2 (ja) 2008-07-09
CN1068314C (zh) 2001-07-11
IL114598A (en) 1999-12-22
FI970147A0 (fi) 1997-01-14
ES2131842T3 (es) 1999-08-01
NO970161L (no) 1997-03-14
US6124294A (en) 2000-09-26
DE59505853D1 (de) 1999-06-10
JPH10502914A (ja) 1998-03-17
BG101113A (en) 1998-04-30
CA2195243A1 (en) 1996-02-01
RU2167869C2 (ru) 2001-05-27
KR970704710A (ko) 1997-09-06
DK0772604T3 (da) 1999-11-01
FI970147A (fi) 1997-01-14
CA2195243C (en) 2006-05-30
WO1996002520A1 (de) 1996-02-01
DE4425144A1 (de) 1996-01-18
AU703889B2 (en) 1999-04-01
EP0772604A1 (de) 1997-05-14
NZ290387A (en) 1999-02-25
BR9508294A (pt) 1997-12-30
GR3030371T3 (en) 1999-09-30
CZ9797A3 (en) 1997-08-13
NO970161D0 (no) 1997-01-14
ATE179703T1 (de) 1999-05-15
SI9520083A (en) 1997-10-31
AU3111395A (en) 1996-02-16
HU225961B1 (en) 2008-01-28

Similar Documents

Publication Publication Date Title
HUT77128A (hu) 1,2,4-Triazol-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HU9700111D0 (en) Use of heterocyclic compounds as dopamines-d3 ligands
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
TW263499B (hu)
IL114600A (en) Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them
IL110582A (en) Substituted azadioxacycloalkenes their preparation and fungicidal compositions containing them
IL115920A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION
AU6360996A (en) Flame-retardant regenerated celluloses
NZ331683A (en) New indole and indazole compounds, a process for their preparation and pharmaceutical compositions containing them
NZ320522A (en) Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
EP0112587A3 (en) Derivatives of 4-(1-(phenyl)-1-(hydroxy)-prop-1-yl)-resorcine, process for their preparation and medicines containing these compounds

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ABBVIE DEUTSCHLAND GMBH & CO KG, DE

Free format text: FORMER OWNER(S): BASF AKTIENGESELLSCHAFT, DE; ABBOTT GMBH & CO. KG, DE

FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: SBGK SZABADALMI ES UEGYVEDI IRODAK, HU